Piroxicam NDC 0093-0756

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-0756Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-0756Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-0756-01	00093075601	100 CAPSULE in 1 BOTTLE (0093-0756-01)Marketed from Oct 19, 1994

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Piroxicam
Generic name (nonproprietary): piroxicam
Active ingredients: Piroxicam — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074131
Marketing start: Oct 19, 1994
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 0093-0756_58e94f5f-1a4d-4dd2-a807-b425a6495052SPL ID 58e94f5f-1a4d-4dd2-a807-b425a6495052SPL set ID f1123fe1-b79c-430b-8548-08cd6e518482RxCUI 198107, 198108UNII 13T4O6VMAM
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093075601 followed by a unit qualifier and the quantity

Package 00093-0756-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 19, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Piroxicam capsules are indicated: For relief of the signs and symptoms of osteoarthritis. For relief of the signs and symptoms of rheumatoid arthritis. Piroxicam capsules are a nonsteroidal anti-inflammatory drug indicated for Relief of the signs and symptoms of osteoarthritis (OA) ( 1 ) Relief of the signs and symptoms of rheumatoid arthritis (RA) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074131

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074131
Product	Strength	Form · route	Labeler	Product NDC
Piroxicam	Piroxicam 20 mg/1	CapsuleOral	Teva Pharmaceuticals USA, Inc.	0093-0757